Total Payments
$5,853
2024 Payments
$618.86
Companies
33
Transactions
379
Medicare Patients
3,710
Medicare Billing
$237,690
Payment Breakdown by Category
Food & Beverage$5,853 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,853 | 379 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,797 | 179 | $0 (2024) |
| GlaxoSmithKline, LLC. | $598.48 | 31 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $414.87 | 18 | $0 (2024) |
| Lilly USA, LLC | $344.96 | 26 | $0 (2024) |
| PFIZER INC. | $338.58 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $294.69 | 20 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $217.95 | 15 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $172.21 | 6 | $0 (2018) |
| Exact Sciences Corporation | $171.02 | 9 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $166.56 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $618.86 | 36 | Novo Nordisk Inc ($172.12) |
| 2023 | $1,126 | 47 | Regeneron Healthcare Solutions, Inc. ($126.00) |
| 2022 | $335.88 | 21 | Novo Nordisk Inc ($144.05) |
| 2021 | $289.61 | 16 | Novo Nordisk Inc ($259.26) |
| 2020 | $162.14 | 15 | Novo Nordisk Inc ($121.95) |
| 2019 | $940.36 | 71 | Novo Nordisk Inc ($300.50) |
| 2018 | $1,132 | 83 | Novo Nordisk Inc ($432.22) |
| 2017 | $1,247 | 90 | Novo Nordisk Inc ($255.77) |
All Payment Transactions
379 individual payment records from CMS Open Payments — Page 2 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Inflammation | ||||||
| 04/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.33 | General |
| 04/03/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Respiratory | ||||||
| 02/22/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Respiratory | ||||||
| 02/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: Obesity | ||||||
| 01/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.03 | General |
| 01/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Oncology | ||||||
| 01/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Inflammation | ||||||
| 12/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Diabetes | ||||||
| 11/20/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: VACCINES | ||||||
| 11/16/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Oncology | ||||||
| 11/08/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Inflammation | ||||||
| 11/02/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: VACCINES | ||||||
| 11/01/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.01 | General |
| 10/12/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: RESPIRATORY | ||||||
| 10/12/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Cardio-renal | ||||||
| 10/05/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Cardiology | ||||||
| 09/29/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Respiratory | ||||||
| 09/21/2023 | The Binding Site Inc. | Freelite (Device) | Food and Beverage | Cash or cash equivalent | $106.74 | General |
| Category: Immunology | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: VACCINES | ||||||
| 09/20/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Obesity | ||||||
| 09/13/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 865 | 1,110 | $103,970 | $57,191 |
| 2022 | 16 | 776 | 989 | $96,615 | $54,372 |
| 2021 | 18 | 997 | 1,328 | $114,484 | $67,462 |
| 2020 | 19 | 1,072 | 1,383 | $115,730 | $58,664 |
Total Patients
3,710
Total Services
4,810
Medicare Billing
$237,690
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 193 | $34,915 | $14,874 | 42.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 110 | 110 | $15,400 | $14,268 | 92.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 124 | 215 | $26,835 | $12,532 | 46.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 22 | $7,810 | $4,617 | 59.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 52 | 52 | $3,640 | $3,567 | 98.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 108 | 108 | $3,240 | $1,986 | 61.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 100 | 100 | $4,500 | $1,839 | 40.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 36 | 36 | $1,260 | $1,125 | 89.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 49 | 106 | $2,130 | $1,009 | 47.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 51 | 54 | $2,160 | $551.31 | 25.5% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 17 | 17 | $510.00 | $300.73 | 59.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 29 | 29 | $290.00 | $177.19 | 61.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 15 | 20 | $800.00 | $155.60 | 19.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 29 | 29 | $290.00 | $147.32 | 50.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 19 | $190.00 | $41.80 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 118 | 222 | $40,945 | $18,170 | 44.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 101 | 101 | $14,140 | $13,432 | 95.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 91 | 143 | $18,495 | $8,059 | 43.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 44 | 45 | $3,150 | $3,074 | 97.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 14 | $4,970 | $2,774 | 55.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 109 | 109 | $3,270 | $2,066 | 63.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $1,980 | $1,881 | 95.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 95 | 95 | $4,275 | $1,769 | 41.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 34 | 34 | $1,190 | $1,017 | 85.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 38 | 79 | $1,580 | $757.30 | 47.9% |
About Dr. Taras Lisowsky, D.O
Dr. Taras Lisowsky, D.O is a Family Medicine healthcare provider based in Warren, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710961990.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Taras Lisowsky, D.O has received a total of $5,853 in payments from pharmaceutical and medical device companies, with $618.86 received in 2024. These payments were reported across 379 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,853).
As a Medicare-enrolled provider, Lisowsky has provided services to 3,710 Medicare beneficiaries, totaling 4,810 services with total Medicare billing of $237,690. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Warren, MI
- Active Since 12/01/2005
- Last Updated 11/08/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1710961990
Products in Payments
- Saxenda (Drug) $558.75
- Victoza (Drug) $335.36
- Wegovy (Drug) $299.02
- TRELEGY ELLIPTA (Drug) $228.58
- Ozempic (Drug) $189.79
- Cologuard Collection Kit (Device) $171.02
- COPAXONE (Drug) $166.56
- TRULICITY (Drug) $155.71
- SYMBICORT (Drug) $140.27
- DUPIXENT (Biological) $126.00
- SOLIQUA (Drug) $124.02
- CHANTIX (Drug) $122.40
- XARELTO (Drug) $115.36
- MYRBETRIQ (Drug) $114.88
- Freelite (Device) $106.74
- PAXLOVID (Drug) $106.63
- INVOKANA (Drug) $102.59
- ENTRESTO (Drug) $97.67
- JARDIANCE (Drug) $91.91
- ANORO (Drug) $88.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Warren
Ping Wang, Md, MD
Family Medicine — Payments: $127,206
Family Medicine $127,206
Dr. Jason Rupeka, Do, DO
Family Medicine — Payments: $65,540
Family Medicine $65,540
Dr. Jacob Bair, D.o, D.O
Family Medicine — Payments: $33,701
Family Medicine $33,701
Saroj Misra, Do, DO
Family Medicine — Payments: $29,024
Family Medicine $29,024
Dr. Kevin Agrest, Do, DO
Family Medicine — Payments: $14,748
Family Medicine $14,748
Dr. Jeffrey Kraft, Do, DO
Family Medicine — Payments: $14,482
Family Medicine $14,482